跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dicaffeoylquinic acid
首页
药物
Dicaffeoylquinic acid
Dicaffeoylquinic acid
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS FOR MAKING BOTANICAL EXTRACT COMPOSITION
EP 3953012 B1
申请人: CARGILL INC
优先权: 2019
CN
EP
US
WO
9 件公开
Methods for making yerba mate extract composition
US 11351214 B2
申请人: CARGILL INC
优先权: 2017
CN
US
WO
4 件公开
Pharmaceutical compositions and uses thereof in treating Parkinson's disease
US 12311005 B2
申请人: LEE TZUNG YAN
优先权: 2020
CN
US
WO
3 件公开
Pharmaceutical compositions and uses thereof in treating muscle atrophy
US 12357665 B2
申请人: LEE TZUNG YAN
优先权: 2020
CN
US
WO
3 件公开
COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING DRY EYE SYNDROME OR MEIBOMIAN GLAND DYSFUNCTION
EP 4487845 A4
申请人: SEOUL NAT UNIV HOSPITAL
优先权: 2022
EP
US
WO
3 件公开
Composition for improvement of muscle function containing 3,5-dicaffeoylquinic acid or chrysanthemum extract
US 11160840 B2
申请人: UNIV YONSEI IACF
优先权: 2016
CN
US
2 件公开
Use of a new composition for preventing or slowing the appearance of signs of inflammation
US 12403077 B2
申请人: SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
优先权: 2018
EP
US
2 件公开
COMPOSITION FOR IMPROVING SKIN BARRIER DAMAGE AND/OR ALLEVIATING SKIN INFLAMMATION, CONTAINING 3,5-DICAFFEOYLQUINIC ACID AS ACTIVE INGREDIENT
WO 2020091440 A9
申请人: UNIV KOREA RES & BUS FOUND
优先权: 2018
CN
WO
2 件公开
SAUSSUREA INVOLUCRATA CELL CULTURE AND USE THEREOF
WO 2025180124 A1
申请人: DALIAN PRACTICAL BIOTECHNOLOGY CO LTD
优先权: 2024
CN
WO
2 件公开
Antiviral compounds and method of treating viral infections
US 2002111382 A1
申请人: CUI XIANGMIN
优先权: 2001
US
第 1 / 6 页
上一页
下一页
药物
反馈